Nesanet S. Mitiku
- ASSISTANT PROFESSOR Rehabilitation Medicine
- ASSISTANT PROFESSOR Neurology
MD, Stanford University Hospital
Internship, Internal Medicine
Highland General Hospital
Residency, Rehabilitation Medicine
University of Washington
Fellowship, Rehabilitation Medicine
University of Washington Medical Center
Dr. Nesanet Mitiku joined the Mount Sinai Departments of Neurology and Rehabilitation in March 2013 and treats patients with multiple sclerosis and related demyelinating disorders. She is also a researcher exploring the reparative and neuroprotective mechanisms relevant to multiple sclerosis.Dr. Mitiku obtained her Bachelor’s in Science in Environmental Systems Engineering, her MD, and her PhD in genetics from Stanford University. She was a resident in the Department of Rehabilitation Medicine at the University of Washington from 2008-2011. Her fellowship in multiple sclerosis was completed at the University of Washington from 2011-2013.
From July 2011 thru January 2013, Dr. Mitiuku was Acting Clinical Instructor at the University of Washington as well as a Staff Physician (WOC) in the Rehabilitation Care Services at the VA Puget Sound Medical Center in Seattle.
Dr. Mitiuku is the recipient of multiple scholarships and awards in teaching, research, and leadership including the K12 RMSTP Career Development Award; the Master MS Fellowship Award; the Foundation of the Consortium of Multiple Sclerosis Centers Scholarship; the MS Awareness Scholarship; the American Academy of Neurology Annual Meeting Fellow Scholarship; the National MS Society Clinical Care Physician Fellowship Award; the Katherine McCormick Research Award (Stanford); the Predoctoral Intramural Research Training Award (NIH); and the GTE/Dean’s Award for Outstanding Leadership (Stanford).
Dr. Mitiku’s primary clinical goal is to help individuals with multiple sclerosis function maximally and achieve the best quality of life possible through individually tailored rehabilitation programs.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Mitiku did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.